Prevalence, Patterns and Reasons for Cannabis Use among Sylvester Comprehensive Cancer Center Patients

This study, funded by the National Cancer Institute, is an online survey conducted in collaboration with 11 other NCI-designated cancer centers to estimate the prevalence and patterns of cannabis use among cancer patients during and after cancer treatment. The Sylvester site encourages participants to provide a urine sample so that cannabinoids can be quantified and studied in the context of cancer-related outcomes. 

COVID-19 Cannabis Health Study

The COVID-19 Cannabis Health Study is an ongoing study to examine the impact of the COVID-19 pandemic on physical and mental health of medical cannabis consumers. Cancer is a qualifying indication for legal medical cannabis use in all states where cannabis is legal in the United States. Preliminary analyses suggest self-titrated cannabis use without discussion with health care providers increased during and after the pandemic. Ongoing data collection now seeks to examine post-pandemic impact on chronic disease patients, such as cancer. 

Psychedelic + Cannabis Patient-Cancer Provider Communication during Cancer Care Delivery

Despite the notable prevalence of cannabis/psychedelics use among cancer patients, there is a dearth in knowledge on patient-provider communication during cancer care delivery. This study aims to 1) provide preliminary estimates of cannabis and psychedelics use among cancer patients within Sylvester facilities; 2) collect cancer patient and provider communication data to inform interventions to improve clinical outcomes in cancer survivors who consume medical cannabis or psychedelics.